Prevalence of Hip Joint Effusion in Children Diagnosed With Transient Synovitis in the Pediatric Emergency Department

Ayelet Shles1,2, Husam Tibi1,2, Nir Friedman1,2

  • 1Pediatric Emergency Department, Meir Medical Center, Kfar Saba.

Insights

Transient synovitis (TS) in children often involves hip effusion, found in 77% of cases. This hip joint effusion is linked to increased pain and tenderness in pediatric patients.

Area of Science:

  • Pediatric Emergency Medicine
  • Pediatric Orthopedics
  • Diagnostic Imaging

Background:

  • Transient synovitis (TS) is a common cause of acute hip pain and limping in children.
  • Hip joint effusion is frequently observed via ultrasonography (US) in TS cases.
  • Limited literature documents the precise prevalence of hip effusion in pediatric TS.

Purpose of the Study:

  • To determine the prevalence of hip joint effusion in children diagnosed with TS in a pediatric emergency department (PED).

Main Methods:

  • Retrospective chart review of pediatric patients diagnosed with TS between 2017 and 2021.
  • Inclusion criteria involved patients undergoing US examination as part of their TS evaluation.
  • Data analysis focused on identifying hip effusion and associated clinical findings.

Main Results:

  • Hip effusion was detected in 302 out of 392 children (77%) diagnosed with TS.
  • Point-of-care ultrasound (POCUS) was performed in 83% of cases by PED physicians.
  • Children with hip effusion exhibited higher pain scores, hip joint tenderness, and elevated CRP levels.

Conclusions:

  • The prevalence of hip joint effusion in children with TS presenting to the PED is 77%.
  • Increased pain levels and hip joint tenderness are associated with the presence of hip effusion.
  • Ultrasonography is a key diagnostic tool for identifying hip effusion in pediatric TS.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
370
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.4K
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
634
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
472
Acute Pyelonephritis I: Introduction01:27

Acute Pyelonephritis I: Introduction

Pyelonephritis is a bacterial infection that primarily affects the renal parenchyma and collecting system, including the renal pelvis, tubules, and interstitial tissue of one or both kidneys. It can be classified as either acute—a sudden, severe infection—or chronic, which refers to long-term or recurrent kidney infections.The primary cause of acute pyelonephritis (APN) is bacterial infection, with Escherichia coli accounting for approximately 70-80% of cases. Other bacteria, such...
1.1K
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.1K